Zuyin Li

Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Immune checkpoint inhibitors use in liver transplantation for hepatocellular carcinoma: a global cohort study.

Immune checkpoint inhibitors use in liver transplantation for hepatocellular carcinoma: a global cohort study.

Journal: BMC medicine
Published: May 27, 2025

MyD88 orchestrates fatty acid metabolism in tumor-associated macrophages and non-alcoholic fatty liver disease-related hepatocarcinogenesis.

MyD88 orchestrates fatty acid metabolism in tumor-associated macrophages and non-alcoholic fatty liver disease-related hepatocarcinogenesis.

Journal: Frontiers in immunology
Published: March 07, 2025

The Emerging Role and Mechanism of E2/E3 Hybrid Enzyme UBE2O in Human Diseases.

The Emerging Role and Mechanism of E2/E3 Hybrid Enzyme UBE2O in Human Diseases.

Journal: Biomedicines
Published: February 28, 2025

Lypd6b depletion promotes CD8+ T cell-mediated anti-tumor immunity via metabolic reprogramming in colorectal cancer.

Lypd6b depletion promotes CD8+ T cell-mediated anti-tumor immunity via metabolic reprogramming in colorectal cancer.

Journal: Nature communications
Published: September 07, 2024

Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinoma.

Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinoma.

Journal: Journal of translational medicine
Published: July 21, 2024

Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8+- T cell-mediated anti-tumor immunity.

Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8+- T cell-mediated anti-tumor immunity.

Journal: Theranostics
Published: April 12, 2024

Integrative analysis reveals different feature of intrahepatic cholangiocarcinoma subtypes.

Integrative analysis reveals different feature of intrahepatic cholangiocarcinoma subtypes.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 16, 2023

Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment.

Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment.

Journal: Frontiers in immunology
Published: December 13, 2021

WWP1 upregulation predicts poor prognosis and promotes tumor progression by regulating ubiquitination of NDFIP1 in intrahepatic cholangiocarcinoma.

WWP1 upregulation predicts poor prognosis and promotes tumor progression by regulating ubiquitination of NDFIP1 in intrahepatic cholangiocarcinoma.

Journal: Cell death discovery
Published: November 18, 2021

Development and Validation of a Novel Hypoxia-Related Long Noncoding RNA Model With Regard to Prognosis and Immune Features in Breast Cancer.

Development and Validation of a Novel Hypoxia-Related Long Noncoding RNA Model With Regard to Prognosis and Immune Features in Breast Cancer.

Journal: Frontiers in cell and developmental biology
Published: October 17, 2021

Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma.

Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma.

Journal: Journal of Cancer
Published: August 03, 2021

Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.

Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.

Journal: Bioscience reports
Published: November 19, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026